Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Phasix Mesh Underlay During Loop Ileostomy Closure

NCT: NCT07871630 · NOT_YET_RECRUITING

NCT IDNCT07871630
StatusNOT_YET_RECRUITING
Start Date2026-10-30
Completion2028-10-30
SponsorCorewell Health West (OTHER)
First posted
Last updated

Brief Summary

This prospective study will evaluate whether placement of long-acting absorbable Phasix mesh during loop ileostomy closure reduces the development of an incisional hernia at the ileostomy closure site in patients with a BMI greater than 25. Participants will undergo mesh-reinforced closure and will be followed for two years after surgery. The primary outcome is development of an incisional hernia at the ileostomy closure site, confirmed by CT imaging at two years.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑